Related references
Note: Only part of the references are listed.Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes
James J. Chamberlain et al.
ANNALS OF INTERNAL MEDICINE (2016)
Atherogenesis: hyperhomocysteinemia interactions with LDL, macrophage function, paraoxonase 1, and exercise
Ilya Chernyavskiy et al.
DIET, SULFUR AMINO ACIDS, AND HEALTH SPAN (2016)
Serum paraoxonase-1 activity and risk of incident cardiovascular disease: The PREVEND study and meta-analysis of prospective population studies
Setor K. Kunutsor et al.
ATHEROSCLEROSIS (2016)
Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases
Massimiliano Castellazzi et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2016)
Oxidative challenge in Alzheimer's disease: state of knowledge and future needs
Carlo Cervellati et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2016)
Association between circulatory levels of adipokines and bone mineral density in postmenopausal women
Carlo Cervellati et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2016)
PON-1 and ferroxidase activities in older patients with mild cognitive impairment, late onset Alzheimer's disease or vascular dementia
Carlo Cervellati et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2015)
Human paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological roles
Mike Mackness et al.
GENE (2015)
Serum paraoxonase and arylesterase activities of paraoxonase-1 (PON-1), mild cognitive impairment, and 2-year conversion to dementia: A pilot study
Carlo Cervellati et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Serum paraoxonase 1 (PON1) measurement: an update
Jose J. Ceron et al.
BMC VETERINARY RESEARCH (2014)
An Effective Approach to High Blood Pressure Control A Science Advisory From the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention
Alan S. Go et al.
HYPERTENSION (2014)
Waist circumference and dual-energy X-ray absorptiometry measures of overall and central obesity are similarly associated with systemic oxidative stress in women
Carlo Cervellati et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2014)
Impaired paraoxonase-1 status in obese children. Relationships with insulin resistance and metabolic syndrome
Natalia Ferre et al.
CLINICAL BIOCHEMISTRY (2013)
Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex
Ying Huang et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Metabolic transitions at menopause: In post-menopausal women the increase in serum uric acid correlates with abdominal adiposity as assessed by DXA
Eleonora Cremonini et al.
MATURITAS (2013)
Adipokines Mediate Inflammation and Insulin Resistance
Hyokjoon Kwon et al.
Frontiers in Endocrinology (2013)
High-Density Lipoprotein Function, Dysfunction, and Reverse Cholesterol Transport
Edward A. Fisher et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Clinical and Genetic Association of Serum Paraoxonase and Arylesterase Activities With Cardiovascular Risk
W. H. Wilson Tang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Cholinesterase and paraoxonase (PON1) enzyme activities in Mexican-American mothers and children from an agricultural community
Veronica Gonzalez et al.
JOURNAL OF EXPOSURE SCIENCE AND ENVIRONMENTAL EPIDEMIOLOGY (2012)
PON-dering differences in HDL function in coronary artery disease
Chieko Mineo et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease
Christian Besler et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
The Scavenger Receptor Class B, Type I Is a Primary Determinant of Paraoxonase-1 Association With High-Density Lipoproteins
Richard W. James et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Homocysteinethiolactone and Paraoxonase Novel markers of diabetic retinopathy
Subramaniam Barathi et al.
DIABETES CARE (2010)
Non-diabetic metabolic syndrome and obesity do not affect serum paraoxonase and arylesterase activities but do affect oxidative stress and inflammation
Suzan Tabur et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
The Role of Adipose Tissue and Adipokines in Obesity-Related Inflammatory Diseases
Carmela Rita Balistreri et al.
MEDIATORS OF INFLAMMATION (2010)
HDL-paraoxonase and Membrane Lipid Peroxidation: A Comparison Between Healthy and Obese Subjects
Gianna Ferretti et al.
OBESITY (2010)
Validation of PON1 enzyme activity assays for longitudinal studies
Karen Huen et al.
CLINICA CHIMICA ACTA (2009)
The measurement of the lactonase activity of paraoxonase-1 in the clinical evaluation of patients with chronic liver impairment
Judit Marsillach et al.
CLINICAL BIOCHEMISTRY (2009)
Novel serum paraoxonase activity assays are associated with coronary artery disease
Nicola Martinelli et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2009)
The paraoxonases: role in human diseases and methodological difficulties in measurement
Jordi Camps et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2009)
Glycation of paraoxonase-1 inhibits its activity and impairs the ability of high-density lipoprotein to metabolize membrane lipid hydroperoxides
M. Mastorikou et al.
DIABETIC MEDICINE (2008)
Gender related differences in paraoxonase 1 response to high-fat diet-induced oxidative stress
Elena Thomas-Moya et al.
OBESITY (2008)
The catalytic histidine dyad of high density lipoprotein-associated serum paraoxonase-1 (PON1) is essential for PON1-mediated inhibition of low density lipoprotein oxidation and stimulation of macrophage cholesterol efflux
M Rosenblat et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Structural modifications of HDL and functional consequences
G Ferretti et al.
ATHEROSCLEROSIS (2006)
Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities
DI Draganov et al.
JOURNAL OF LIPID RESEARCH (2005)
Paraoxonase activity in high-density lipoproteins: A comparison between healthy and obese females
G Ferretti et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Modulation of paraoxonase (PON1) activity
LG Costa et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes
M Harel et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2004)
Lactonase and lactonizing activities of human serum paraoxonase (PON1) and rabbit serum PON3
JF Teiber et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Regulation of serum paraoxonase activity by genetic, nutritional, and lifestyle factors in the general population
N Ferré et al.
CLINICAL CHEMISTRY (2003)
Low paraoxonase activity predicts coronary events in the caerphilly prospective study
B Mackness et al.
CIRCULATION (2003)
Expression of major HDL-associated antioxidant PON-1 is gender dependent and regulated during inflammation
A Bin Ali et al.
FREE RADICAL BIOLOGY AND MEDICINE (2003)
Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: Studies in PON1-knockout mice
O Rozenberg et al.
FREE RADICAL BIOLOGY AND MEDICINE (2003)
Obesity and systemic oxidative stress - Clinical correlates of oxidative stress in the Framingham Study
JF Keaney et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice
A Tward et al.
CIRCULATION (2002)
Using a modified ferrous oxidation-xylenol orange (FOX) assay for detection of lipid hydroperoxides in plant tissue
JM DeLong et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2002)
Paraoxonase status in coronary heart disease - Are activity and concentration more important than genotype?
B Mackness et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Share Paper
